Genomic coamplification of CDK4 / MDM2 / FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients-Reference-Cited by-同舟云学术

Genomic coamplification of CDK4 / MDM2 / FRS2 is associated with very poor prognosis and atypical clinical features in neuroblastoma patients

Published:2019-12-03 Issue:5 Volume:59 Page:277-285
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosomes Cancer

Author:

Amoroso Loredana¹^ORCID,Ognibene Marzia²^ORCID,Morini Martina³,Conte Massimo¹,Di Cataldo Andrea⁴,Tondo Annalisa⁵,D'Angelo Paolo⁶,Castellano Aurora⁷,Garaventa Alberto¹,Lasorsa Vito A.⁸⁹,Podestà Marina²,Capasso Mario⁸⁹,Pezzolo Annalisa²^ORCID

Affiliation:

1. UOC OncologiaIRCCS Istituto Gaslini Genova Italy

2. Laboratorio Cellule Staminali e Terapie CellulariIRCCS Istituto Gaslini Genova Italy

3. Laboratorio di Biologia MolecolareIRCCS Istituto Gaslini Genova Italy

4. UOC Emato‐oncologiaPoliclinico di Catania Catania Italy

5. UOC Oncologia PediatricaOspedale Meyer Firenze Italy

6. UOC Onco‐ematologia PediatricaOspedale dei Bambini Palermo Italy

7. UOC Oncologia PediatricaOspedale Bambino Gesù Roma Italy

8. Dipartimento di Medicina Molecolare e Biotecnologie MedicheUniversità degli Studi di Napoli Federico II Naples Italy

9. CEINGE Biotecnologie Avanzate Naples Italy

Publisher

Wiley